Leal A, Liby K
Int J Mol Sci. 2024; 25(18).
PMID: 39337472
PMC: 11432103.
DOI: 10.3390/ijms25189985.
Daher H, Punchayil S, Ismail A, Fernandes R, Jacob J, Algazzar M
Cureus. 2024; 16(3):e56583.
PMID: 38646386
PMC: 11031195.
DOI: 10.7759/cureus.56583.
Amo-Aparicio J, Dominguez A, Atif S, Dinarello A, Azam T, Alula K
Cancer Res Commun. 2023; 3(9):1899-1911.
PMID: 37772994
PMC: 10510589.
DOI: 10.1158/2767-9764.CRC-23-0065.
Yoon S, Park S, Kim H, Shin S, Heo J, Rhu J
Cancer Res Treat. 2023; 55(3):948-955.
PMID: 36915251
PMC: 10372597.
DOI: 10.4143/crt.2023.290.
Chen S, Zhou S, Huang Y, Yuan M, Lei W, Chen J
Int J Mol Sci. 2022; 23(23).
PMID: 36499343
PMC: 9736800.
DOI: 10.3390/ijms232315020.
Low Pre-ChemoradiotherapyPan-Immune-Inflammation Value (PIV) Measures Predict Better Survival Outcomes in Locally Advanced Pancreatic Adenocarcinomas.
Topkan E, Selek U, Kucuk A, Pehlivan B
J Inflamm Res. 2022; 15:5413-5423.
PMID: 36158517
PMC: 9499729.
DOI: 10.2147/JIR.S385328.
Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma.
Liu Y, Hu C, Hsu Y, Lee W
Cell Death Dis. 2022; 13(9):817.
PMID: 36151074
PMC: 9508091.
DOI: 10.1038/s41419-022-05259-w.
Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression.
McCubrey J, Yang L, Abrams S, Steelman L, Follo M, Cocco L
Cells. 2022; 11(14).
PMID: 35883598
PMC: 9318640.
DOI: 10.3390/cells11142155.
Postchemoradiotherapy Neutrophil-to-Lymphocyte Ratio Predicts Distant Metastasis and Survival Results in Locally Advanced Pancreatic Cancers.
Topkan E, Selek U, Haksoyler V, Kucuk A, Kilic Durankus N, Sezen D
Int J Clin Pract. 2022; 2022:7473649.
PMID: 35685603
PMC: 9159257.
DOI: 10.1155/2022/7473649.
Combination of LIGHT (TNFSF14)-Armed Myxoma Virus Pre-Loaded into ADSCs and Gemcitabine in the Treatment of Experimental Orthotopic Murine Pancreatic Adenocarcinoma.
Jazowiecka-Rakus J, Sochanik A, Hadrys A, Fidyk W, Chmielik E, Rahman M
Cancers (Basel). 2022; 14(8).
PMID: 35454928
PMC: 9027757.
DOI: 10.3390/cancers14082022.
Development and external validation of a nomogram with inflammatory markers for predicting invasiveness of intraductal papillary mucinous neoplasm of pancreas.
Yoon S, Kim H, Lee O, Jung J, Lim C, Shin Y
Medicine (Baltimore). 2022; 101(11).
PMID: 35356913
PMC: 10684245.
DOI: 10.1097/MD.0000000000029036.
Cancer-inducing niche: the force of chronic inflammation.
Afify S, Hassan G, Seno A, Seno M
Br J Cancer. 2022; 127(2):193-201.
PMID: 35292758
PMC: 9296522.
DOI: 10.1038/s41416-022-01775-w.
Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer.
Alam A, Levanduski E, Denz P, Villavicencio H, Bhatta M, Alhorebi L
Cancer Cell. 2022; 40(2):153-167.e11.
PMID: 35120601
PMC: 8847236.
DOI: 10.1016/j.ccell.2022.01.003.
Circulating Inflammation Markers and Pancreatic Cancer Risk: A Prospective Case-Cohort Study in Japan.
Ma E, Shimazu T, Song M, Charvat H, Sawada N, Yamaji T
Cancer Epidemiol Biomarkers Prev. 2021; 31(1):236-241.
PMID: 34697062
PMC: 8755613.
DOI: 10.1158/1055-9965.EPI-21-0808.
NF-κB and Pancreatic Cancer; Chapter and Verse.
Silke J, OReilly L
Cancers (Basel). 2021; 13(18).
PMID: 34572737
PMC: 8469693.
DOI: 10.3390/cancers13184510.
Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis.
Del Poggetto E, Ho I, Balestrieri C, Yen E, Zhang S, Citron F
Science. 2021; 373(6561):eabj0486.
PMID: 34529467
PMC: 9733946.
DOI: 10.1126/science.abj0486.
The Prognostic Significance of Novel Pancreas Cancer Prognostic Index in Unresectable Locally Advanced Pancreas Cancers Treated with Definitive Concurrent Chemoradiotherapy.
Topkan E, Selek U, Pehlivan B, Kucuk A, Haksoyler V, Kilic Durankus N
J Inflamm Res. 2021; 14:4433-4444.
PMID: 34511977
PMC: 8427684.
DOI: 10.2147/JIR.S329611.
Endogenous and Therapeutic Estrogens: Maestro Conductors of the Microenvironment of ER+ Breast Cancers.
Schuler L, Murdoch F
Cancers (Basel). 2021; 13(15).
PMID: 34359625
PMC: 8345134.
DOI: 10.3390/cancers13153725.
Pancreatic Cancer: A Review of Risk Factors, Diagnosis, and Treatment.
Zhao Z, Liu W
Technol Cancer Res Treat. 2020; 19:1533033820962117.
PMID: 33357065
PMC: 7768873.
DOI: 10.1177/1533033820962117.
Expression of POU2F3 Transcription Factor Control Inflammation, Immunological Recruitment and Metastasis of Pancreatic Cancer in Mice.
Bintz J, Abuelafia A, Gerbe F, Baudoin E, Auphan-Anezin N, Sidot E
Biology (Basel). 2020; 9(10).
PMID: 33086657
PMC: 7603360.
DOI: 10.3390/biology9100341.